Exceet Group SE reported earnings results for the year 2011. For the year 2011, the company's group sales rose by 42.7% to EUR 170.5 million compared to EUR 119.4 million a year ago. The group achieved organic growth of 10.8%. Sales growth was driven primarily by strong demand in the medical technology and industrial automation divisions. The EBITDA, before one-time IPO/SPAC costs was EUR 3.4 million as well as restructuring provisions of EUR 1.0 million, increased by 62.9% year-on-year to EUR 28.8 million compared to EUR 17.7 million in 2010. This led to an EBITDA margin of 16.9% compared to 14.8% a year ago. The adjusted EBIT increased significantly by 74.3% to EUR 20.7 million compared to EUR 11.9 million in 2010. This corresponds to an EBIT margin of 12.1% compared to 9.9% a year ago. Earnings after tax rose by 62.4% to EUR 14.7 million compared to EUR 9.1 million a year ago. Earnings per share were EUR 1.45 compared to EUR 2.95 a year ago. The company provided earnings guidance for the year 2012. For the year 2012, the company targets to increase turnover by at least 20% per year. The company expects this positive trend to continue during the course of this year and assumes that the adjusted EBITDA margin will be in line with the previous year's figure. The group is firmly committed to the medium-term target of achieving an EBITDA margin of 18%.